Drugs / Biocon's Human Insulin R U-500
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05413863 | May → Dec 2022 | — | Biocon Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biocon's Human Insulin R U-500 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05413863 ↗ |
| Known as | Insulin Human Injection 500 units/mL | “Biocon's Human Insulin R U-500 (Insulin Human Injection 500 units/mL), 3 mL cartridges (containing 1,500 units of insulin).” NCT05413863 ↗ |
| Route | Subcutaneous | “Biocon's Human Insulin R U-500 single subcutaneous dose of 0.3 IU/kg” NCT05413863 ↗ |